Skip to Content

Press Releases

The information and content in this site has been released in the past by Express Scripts Holding Company or its predecessor and wholly-owned subsidiary, Express Scripts, Inc. (together, Express Scripts). These contents may no longer be current. The passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. On the date released, some of the contents in this site may have contained statements that were then "forward-looking statements," based upon then current expectations, forecasts and assumptions that involved risks and uncertainties, then enumerated by Express Scripts that could cause actual outcomes and results to differ materially. To the extent any information is forward-looking, it is intended to comply with the safe harbor for forward-looking information as of the date of issuance (for more information, view our forward-looking statement). Express Scripts disclaims any intention or obligation to update or revise the contents of this site, including but not limited to any forward-looking statements made at the time the information was first released, whether as a result of new information, future events or otherwise.

Archived Press Releases

Date Title and Summary
Toggle Summary Express Scripts Reminds Stockholders to Vote "FOR" the Merger with Cigna
Special Meeting of Stockholders to Vote on the Transaction to be held on Friday, August 24, 2018 Leading Independent Proxy Advisory Firms ISS, Glass Lewis and Egan Jones Support the Combination ST. LOUIS , Aug. 16, 2018 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) today reminded its stockholders
Toggle Summary Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement with Cigna
Express Scripts Reminds Stockholders to Vote "FOR" the Merger ST. LOUIS , Aug. 13, 2018 /PRNewswire/ --  Express Scripts  (NASDAQ: ESRX) today announced that Glass, Lewis & Co., LLC (" Glass Lewis "), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote
Toggle Summary Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote "FOR" Merger with Cigna
ST. LOUIS , Aug. 10, 2018 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) today announced that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote " FOR " Express Scripts' merger agreement with Cigna
Toggle Summary Express Scripts Announces New Recommendations Tackling High Drug Prices
- 2019 National Preferred Formulary includes low list price medications in high-cost categories - Fewer than 0.2 percent of members will see a change in coverage for a medication - Changes in 2019 will save plans an estimated $3.2 billion; cumulative savings for plans leveraging NPF since 2014 will
Toggle Summary Express Scripts Announces 2018 Second Quarter Results
- Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth - Raises Core Adjusted EBITDA Guidance Range - Increases Client Retention Level - Projects 2% to 3% Core Adjusted Claims Growth for 2019 ST. LOUIS , Aug. 1, 2018 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX)
Toggle Summary Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis
eviCore Medical Benefit Management Opens New Provider Service Center ST. LOUIS and BLUFFTON, S.C. , July 18, 2018 /PRNewswire/ -- eviCore healthcare, a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), is adding 100 jobs in St. Louis as part of expanding its services to healthcare
Toggle Summary Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details
St. Louis , July 12, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2018 second quarter financial results on Wednesday, August 1, 2018 , after the market closes.
Toggle Summary Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS , July 11, 2018 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) was again recognized with a 100 percent score on the Disability Equality Index® (DEI) for its ongoing commitment to being inclusive and welcoming to people of all abilities. The DEI is a national benchmarking tool and joint
Toggle Summary Express Scripts' Physician-Minded Solutions Deliver Greater Price Transparency, Medication Safety and Coordination of Care
Industry leading, data-driven tools and programs help prescribers make the best therapy decisions for patients at the point-of-care ST. LOUIS , June 7, 2018 /PRNewswire/ -- A suite of high-impact, data-driven engagement programs from Express Scripts (NASDAQ: ESRX) are simplifying the prescribing
Toggle Summary Pharmacy Everywhere: Express Scripts and MedAvail Announce Collaboration to Make Pharmacy More Affordable and Convenient
Collaboration to examine how automated, self-service pharmacy centers can provide insured, underinsured and uninsured patients with a more affordable and convenient pharmacy experience ST. LOUIS , June 6, 2018 /PRNewswire/ -- Convenience is the new currency among consumers looking for faster,
Toggle Summary Express Scripts to Provide Patients with Faster Path to Rare Disease Diagnosis and Treatment, in Collaboration with PinnacleCare
New Rare Conditions Care Value Program(SM) expands support services to facilitate second opinion that can improve health outcomes, reduce wasteful spending ST. LOUIS and BALTIMORE , May 31, 2018 /PRNewswire/ -- For any patient with a rare disease, the journey to the right diagnosis and treatment
Toggle Summary Express Scripts Statement on Administration's Comments on Drug Pricing
ST. LOUIS , May 11, 2018 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) released the following statement in response to the Administration's announcement today on prescription drug costs: "President Trump rightly recognizes drug companies charge way too much, and their prices need to come down.
Toggle Summary Innovative Value-based SafeGuardRx® Program Delivers Better Care at Lower Cost for Express Scripts' Patients and Plan Sponsors
ST. LOUIS , May 10, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx®
Toggle Summary Express Scripts Announces 2018 First Quarter Results
ST. LOUIS , May 2, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted share was $1.77 .* The Company reaffirms its core
Toggle Summary Express Scripts Ranked as a Top 50 Inclusive company by DiversityInc
ST. LOUIS , May 2, 2018 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX), through its commitment to diversity and inclusion, has earned recognition among the Top 50 inclusive companies in the nation by DiversityInc, it was announced today. "We are proud to be recognized by DiversityInc for creating
Toggle Summary "Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications
Medication Reminders from Spouses are Not Appreciated While Technology Assistance Is ST. LOUIS , April 25, 2018 /PRNewswire/ -- Many Americans on medications for chronic diseases are not concerned about missing doses, resent their spouses/partners reminding them to take their medicine and think
Toggle Summary Express Scripts Holding Company Announces First Quarter 2018 Earnings Release Details
St. Louis , April 13, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2018 first quarter financial results on Wednesday, May 2, 2018 , after the market closes. Management will not be holding a conference call
Toggle Summary Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans
ST. LOUIS , April 12, 2018 /PRNewswire/ -- Guided by the principles of simplification, choice, and competition, Express Scripts (NASDAQ: ESRX) today announced the launch of a new, innovative 12-month pilot for a performance-based retail pharmacy network for commercial plans designed to optimize
Toggle Summary Express Scripts Names Ron Guerrier Chief Information Officer
ST. LOUIS , April 3, 2018 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Ron Guerrier will join the company as Chief Information Officer, effective April 16, 2018 . He will be responsible for the company's strategic investments in and application of technology
Toggle Summary Express Scripts Names Mike Cirillo President of myMatrixx
ST. LOUIS , April 2, 2018 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Mike Cirillo has been named President of myMatrixx, an Express Scripts company. Mike will replace Artemis Emslie, who will stay with myMatrixx until the end of May to assist with the
Toggle Summary Express Scripts Endorses "Know the Lowest Price Act of 2018" and "Patient Right to Know Drug Prices Act"
ST. LOUIS , March 16, 2018 /PRNewswire/ -- Express Scripts (NASDAQ:ESRX) today released this statement in support of S. 2553, the "Know the Lowest Price Act of 2018," introduced by U.S. Senators Stabenow, Collins , Wyden, Cassidy, McCaskill and Barrasso, and S.
Toggle Summary Express Scripts Holding Company to Cancel Investor Day Meeting
ST. LOUIS , March 14, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today it cancelled its previously announced investor day meeting, which was scheduled to be held in New York City on May 2, 2018 , at 8:00 a.m. Eastern Time ( 7:00 a.m.
Toggle Summary Cigna to Acquire Express Scripts for $67 Billion
Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler Creates an expanded portfolio of health services with greater choice, alignment and value across a proven services platform Expands distribution of health services for
Toggle Summary Express Scripts Awarded National Recognition for Fighting the Opioid Epidemic
ST. LOUIS , March 6, 2018 /PRNewswire/ -- On Tuesday, Express Scripts (NASDAQ: ESRX) was awarded the Pharmacy Benefit Management Institute's (PBMI) Excellence Award in the Opioid Management Strategy Category.  The award comes in recognition of the ground breaking ways Express Scripts is helping
Toggle Summary Express Scripts Announces 2017 Fourth Quarter and Full Year Results
ST. LOUIS , Feb. 27, 2018 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2017 fourth quarter and full year net income of $2,327.6 million and $4,517.4 million , respectively, or $4.10 and $7.74 per diluted share, respectively.
Toggle Summary Express Scripts Holding Company Announces Webcast of Investor Day Meeting
ST. LOUIS , Feb. 21, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today it has scheduled an investor day meeting in New York City on May 2, 2018 , at 8:00 a.m. Eastern Time ( 7:00 a.m. Central Time ) at The Roosevelt Hotel New York .  At the
Toggle Summary Express Scripts and Walgreens Boots Alliance Expand Group Purchasing Efforts to Include Specialty Brand Medications
ST. LOUIS and DEERFIELD, Ill. , Feb. 20, 2018 /PRNewswire/ --  Express Scripts Holding Company (NASDAQ: ESRX) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA ) today announced they are expanding their group purchasing efforts to include the procurement of specialty brand drugs.  Given the savings
Toggle Summary Express Scripts Reduces Employers' Annual Prescription Drug Spending Growth Rate to Historic Low in 2017
ST. LOUIS , Feb. 6, 2018 /PRNewswire/ -- At a time when consumers, businesses and policymakers are intensely focused on reducing prescription drug costs, Express Scripts (NASDAQ: ESRX) helped employers reduce the rate of growth in per-person prescription drug spending to 1.5 percent in 2017,
Toggle Summary Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
St. Louis , Jan. 15, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018 , after the market closes and will hold its quarterly
Toggle Summary Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients
WASHINGTON , Jan. 11, 2018 /PRNewswire/ -- During a briefing on meaningful solutions for safer opioid prescribing with Congressional Representatives Ann McLane Kuster (D-NH) and Tom MacArthur (R-NJ), Express Scripts (NASDAQ: ESRX) today announced that an initial 90-day review of its Advanced Opioid
Toggle Summary Express Scripts' Accredo Earns Renewed URAC Specialty Pharmacy Accreditation
ST. LOUIS , Jan. 10, 2018 /PRNewswire/ -- Accredo ® specialty pharmacy, a subsidiary of Express Scripts (NASDAQ: ESRX), has earned URAC's specialty pharmacy accreditation at its primary dispensing locations: Warrendale, Pa. , New Castle, Del. , Indianapolis, Ind. , Orlando, Fla. , Memphis, Tenn.
Toggle Summary Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS , Jan. 2, 2018 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 3:00 p.m. Pacific Standard Time ( 6:00 p.m.
Toggle Summary Express Scripts Closes Acquisition Of eviCore; Companies Unite To Improve Healthcare For 100 Million Americans
- Improves ability to attack enormous inefficiencies and address unnecessary spending - Leverages evidence-based medicine, advanced data analytics and clinical specialization to improve care and control cost across pharmacy and medical platforms - Delivers accretion to growth, earnings and cash
Toggle Summary Express Scripts Holding Company Updates 2017 Full-Year Guidance and Announces 2018 Financial Guidance
ST. LOUIS , Dec. 14, 2017 /PRNewswire/ --   Express Scripts Holding Company (Nasdaq: ESRX) increased its previously issued consolidated 2017 full-year adjusted EPS guidance range of $6.97 to $7.05 to $7.00 to $7.08 , which represents growth of 10% over consolidated 2016 adjusted EPS results at the
Toggle Summary Avista Capital Partners to Acquire Express Scripts' Subsidiary United BioSource
ST. LOUIS and NEW YORK , Nov. 27, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) and Avista Capital Partners , a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding
Toggle Summary Express Scripts Holding Company Announces 2018 Financial Guidance Conference Call
ST. LOUIS , Nov. 9, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2018 financial guidance on Thursday, December 14, 2017 , via press release before the market opens, followed by a conference call to discuss the 2018 financial
Toggle Summary Express Scripts Recognized as a Best Place to Work for LGBTQ Equality
ST. LOUIS , Nov. 9, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) has received a perfect score of 100 on the 2018 Corporate Equality Index, a national benchmarking report on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality,
Toggle Summary Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS , Oct. 30, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 7, 2017 at 9:45 a.m. MST ( 11:45 a.m.
Toggle Summary Express Scripts Appoints James M. Havel Chief Financial Officer
ST. LOUIS , Oct. 24, 2017 /PRNewswire/ --  Express Scripts Holding Company (NASDAQ: ESRX) today announced that James M. Havel , who previously served as Express Scripts' Executive Vice President, has been named Executive Vice President and Chief Financial Officer, effective October 25, 2017 .
Toggle Summary Express Scripts Announces 2017 Third Quarter Results
ST. LOUIS , Oct. 24, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 third quarter net income of $841.7 million or $1.46 per diluted share.  2017 third quarter adjusted earnings per diluted share was $1.90 .*   "We have taken significant steps forward this year
Toggle Summary New Research: Affordability and Access to Prescription Medications Take Center Stage in Selecting a Medicare Plan
ST. LOUIS , Oct. 18, 2017 /PRNewswire/ -- Medicare can be an alphabet soup (Part D; MA-PD; MA), but according to research released today by Express Scripts (NASDAQ: ESRX), seniors understand the value offered by these plans, especially when it comes to prescription medications.
Toggle Summary Express Scripts to Acquire eviCore healthcare; Accelerates Company's Shift to Patient Benefit Management
- Improves ability to address $1 trillion annually wasted on unnecessary healthcare spending - Establishes cornerstone platform to rapidly advance into Medical Benefits Management Services, a large and growing market - Creates a comprehensive suite of data-driven service solutions with
Toggle Summary A New Normal? 870,000 Americans Used $50,000 Worth or More of Prescription Medicine in 2016
- New Express Scripts research shows in 2016, an estimated 870,000 Americans reached or exceeded a yearly medication cost threshold of $50,000, up 35 percent from 2014. - Less than one-third of one percent of the U.S. population accounted for an estimated $80 billion of total U.S. drug spending.
Toggle Summary Express Scripts Introduces New Medicare Part D Saver Plan for 2018
New Saver Plan offers a low monthly premium and a preferred pharmacy network featuring CVS Pharmacy and Kroger. ST. LOUIS , Oct. 2, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today introduced a new Express Scripts Medicare ® Prescription Drug Plan (PDP) for 2018 called the Saver plan, a
Toggle Summary Express Scripts Offers Important Prescription Drug Information for Residents Impacted by Hurricane Irma
ST. LOUIS , Sept. 7, 2017 /PRNewswire/ -- Express Scripts is providing the following information to assist residents impacted by Hurricane Irma in Florida , Georgia and Puerto Rico who have prescription coverage through Express Scripts . WHO:  All people who have a pharmacy benefit administered by
Toggle Summary Express Scripts Holding Company Announces Third Quarter 2017 Earnings Conference Call
St. Louis , Sept. 05, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 third quarter financial results on Tuesday, October 24, 2017 after the market closes and will hold its quarterly conference call to
Toggle Summary Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS , Aug. 30, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the 2017 Wells Fargo Healthcare Conference on Wednesday, September 6, 2017 at 9:05 a.m. eastern ( 8:05 a.m. central).
Toggle Summary Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications
ST. LOUIS , Aug. 25, 2017 /PRNewswire/ -- New research released today by Express Scripts (NASDAQ: ESRX) reveals that commercially insured people who were adherent to their oral diabetes medications experienced significantly fewer emergency room visits and inpatient hospitalizations, and spent
Toggle Summary Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS , Aug. 23, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) was recognized today as a top-scoring company on the Disability Equality Index® (DEI) for having inclusive workplace, social and governance policies. The DEI is a national benchmarking tool and joint initiative of the
Toggle Summary Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS , Aug. 23, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) was recognized today as a top-scoring company on the Disability Equality Index® (DEI) for having inclusive workplace, social and governance policies. The DEI is a national benchmarking tool and joint initiative of the